疾病稳定性是否可作为慢阻肺可实现的治疗目标?
慢阻肺虽在急性加重、生活质量与肺功能等方面有治疗进展,但许多患者难以达到改善,且因疾病进展性难以设定管理目标。作者据此提出「疾病稳定性」作为合适且可实现的治疗目标,借鉴其他疾病领域的无疾病活动或缓解定义,并基于慢阻肺已有的临床控制与临床重要恶化等概念,提出初步定义框架,尚需进一步验证。
要点
- 对许多慢阻肺患者,改善可能难以实现,疾病稳定性可作为可实现的治疗目标。
- 稳定性定义可纳入急性加重、健康状况(含生活质量与症状)和肺功能等组分。
- 需考虑稳定性评估的时间间隔、合适阈值及复合定义,并需进一步研究验证。
核心结论
- 作者提出将疾病稳定性作为慢阻肺合适且可实现的治疗目标,并给出基于现有研究的初步定义框架,尚需验证。
研究设计与样本
- 本文为综述/观点类文章,基于慢阻肺现有研究提出疾病稳定性的初步定义框架,未报告系统检索范围与样本量。
主要发现
- 尽管临床试验显示急性加重、生活质量和肺功能等结局有改善,但改善对许多患者可能不可及。
- 对经历改善的患者,因慢阻肺的进展性,设定管理目标具有挑战性。
- 其他疾病领域已建立无疾病活动或缓解的定义,可为慢阻肺稳定性的定义与实现提供参考。
- 疾病稳定性建立在慢阻肺已定义的临床控制和临床重要恶化等相关概念之上。
关键数值与推荐
- 可构成疾病稳定性定义的现有组分包括急性加重、健康状况(含生活质量和症状)以及肺功能。
- 定义和评估稳定性时需考虑时间间隔、合适阈值以及复合定义的构建。
临床怎么用
- 临床可与患者沟通以疾病稳定性为治疗目标,并采用整体方法、客观测量及清晰一致的沟通支持其建立。
局限性
- 本文提出的疾病稳定性定义为初步框架,需进一步研究在临床和研究环境中验证后方可使用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic obstructive pulmonary disease (COPD) is a heterogeneous lung condition characterized by progressive airflow obstruction. Despite advancements in diagnosis and treatment, the disease burden remains high; although clinical trials have shown improvements in outcomes such as exacerbations, quality of life, and lung function, improvement may not be attainable for many patients. For patients who do experience improvement, it is challenging to set management goals given the progressive nature of COPD. We therefore propose disease stability as an appropriate and attainable treatment goal. Other disease areas have developed definitions of no disease activity or remission, which provide relevant information for defining and achieving stability for patients with COPD. Disease stability builds on related concepts already defined in COPD, such as clinical control and clinically important deterioration. Current components that could form part of a disease stability definition include exacerbations, health status (including quality of life and symptoms), and lung function. Considerations should be given to intervals over which stability is defined and assessed, appropriate thresholds, and defining a composite. Ensuring a holistic approach, objective measurements, and harmonious, clear communication between patients and physicians can further support establishing disease stability. Here we propose a preliminary definition of disease stability, informed by existing research in COPD. Further research will be needed to validate the framework for use in clinical and research settings. Exploring disease stability as a goal, however, is an opportunity to develop and validate an attainable treatment target to advance the standard of care for patients with COPD.
引用
- Singh D, Han MK, Bhatt SP, et al. Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal? Am J Respir Crit Care Med. 2025. PMID: 39680953. doi:10.1164/rccm.202406-1254CI
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。